Board meeting scheduled for May 7, 2026 to approve audited standalone financial results for Q4 and year ended March 31, 2026.
Board to consider recommendation of final dividend on equity shares for FY26, subject to approval.
Meeting will be held at company's registered office and includes statutory auditor reports review.
Disclosure made pursuant to SEBI Listing Regulations Regulation 29 for shareholder information.